Plus   Neg

Myriad Genetics Inc. Q4 Earnings Decline 21%

Myriad Genetics Inc. (MYGN) released a profit for fourth quarter that dropped from last year.

The company said its earnings fell to $20.8 million, or $0.30 per share. This was down from $26.4 million, or $0.36 per share, in last year's fourth quarter.

Analysts had expected the company to earn $0.26 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 7.5% to $200.5 million. This was up from $186.5 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q4): $20.8 Mln. vs. $26.4 Mln. last year.
-Earnings Decline (Y-o-Y): -21.2%
-EPS (Q4): $0.30 vs. $0.36 last year.
-EPS Decline (Y-o-Y): -16.7%
-Analysts Estimate: $0.26
-Revenue (Q4): $200.5 Mln vs. $186.5 Mln last year.
-Revenue Change (Y-o-Y): 7.5%

Next quarter EPS guidance: $0.19 - $0.21
Next quarter revenue guidance: $181-$183 Mln

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Follow RTT